Literature summary for 2.7.10.1 extracted from

Wong, C.I.; Yap, H.L.; Lim, S.G.; Guo, J.Y.; Goh, B.C.; Lee, S.C.
Lack of somatic ErbB2 tyrosine kinase domain mutations in hepatocellular carcinoma (2008), Hepatol. Res., 38, 838-841.

Search for more literature for 2.7.10.1

Application

Application	Comment	Organism
medicine	no exonic mutation in the tyrosine kinase domain of ErbB2 in Asian hepatocellular carcinoma patients. Alternative mechanisms may be responsible for the observed efficacy of ErB1 and ErbB2 tyrosine kinase inhibitors	Homo sapiens

Organism

Organism	UniProt	Comment	Textmining
Homo sapiens	-	-	-

Source Tissue

Source Tissue	Comment	Organism	Textmining
additional information	hepatocellular carcinoma tissue	Homo sapiens	-

Synonyms

Synonyms	Comment	Organism
ErbB2 tyrosine kinase	-	Homo sapiens

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)